African Cancer Genome: GMD

African Cancer Genome: GMD
Information from the National Library of Medicine NIH NLM ABRV BLK 4

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05754658

Layout table for location information
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States, 19111
Contact: CAMILLE RAGIN, PhD, MPH    215-728-1148    camille.ragin@fccc.edu   
Contact: SOPHIA GEORGE, PhD       Sophia.george@med.miami.edu   

Fox Chase Cancer Center

University of Miami Sylvester Comprehensive Cancer Center

Pfizer

The University of The West Indies, Mona, Jamaica

Kenya Medical Research Institute

University of Nairobi, Kenya

University of Abomey Calavi, Benin

Innovating Health International, Haiti

Institut de Recherche en Sciences de la Sante, Burkina Faso

The University of the West Indies at Cave Hill, Barbados

The University of The West Indies School of Clinical Medicine and Research, The Bahamas

Ministry of Health and Social Services, Namibia

Morgan State University

University of Alabama, Tuscaloosa

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

March 7, 2023Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments